Ocular Therapeutix Inc — Quarterly Financial Statistics (NASDAQ:OCUL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -39.43 M-44.67 M-55.24 M-50.73 M-54.25 M -204.88 M Cash from investing activities -202 K-1.93 M-1.11 M-5.99 M-2.84 M -11.88 M Cash from financing activities 4.51 M4.18 M97.81 M10.36 M449.38 M 561.72 M Free cash flow -39.63 M-46.6 M-56.48 M-56.72 M-57.09 M -216.89 M

뉴스

Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?

EyePoint: The 'Pre-Readout' Surge Is Hiding A Commercial Reality Check (NASDAQ:EYPT)

Ocular Therapeutix, Inc. (OCUL) Presents at 49th Annual Meeting of the Macula Society - Slideshow (NASDAQ:OCUL) 2026-03-03

Ocular Therapeutix, wAMD 데이터에 목표 주가 상향 – Clear Street

Clear Street raises Ocular Therapeutix price target on wAMD data

Palantir, United Tech among market cap stock movers on Monday

오큘라 테라퓨틱스, TD 코웬 컨퍼런스: AXPAXLI 전략적 통찰

Ocular Therapeutix at TD Cowen Conference: Strategic Insights on AXPAXLI

윌리엄 블레어, Ocular Therapeutix에 대한 투자의견 재확인

William Blair reiterates Ocular Therapeutix stock rating on trial data

Ocular Therapeutix, CSO Heier, 주식 2.5만 달러 매도

Ocular Therapeutix, 최고 개발 책임자 Kaiser, 2.3만 달러 상당 주식 매도